Publicaciones en las que colabora con Miguel Ángel Moreno Romo (14)

2020

  1. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2013

  1. Change of integrons over time in Escherichia coli isolates recovered from healthy pigs and chickens

    Veterinary Microbiology, Vol. 163, Núm. 1-2, pp. 124-132

2010

  1. Prudent use of antimicrobial agents: Not just for humans

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 10, pp. 669-671

  2. Resistance mechanisms and holding-level distribution of faecal Escherichia coli isolates resistant to extended-spectrum cephalosporins in pigs in Spain

    Research in Veterinary Science, Vol. 88, Núm. 1, pp. 83-87

2009

  1. Occurrence of extended-spectrum beta-lactamase producing Salmonella enterica in North Spain with evidence of CTX-M-9 clonal spread among animals and humans

    Clinical Microbiology and Infection, Vol. 15, Núm. 3, pp. 292-295

  2. Prevalence and diversity of Extended-Spectrum Beta-Lactamases in faecal Escherichia coli isolates of healthy humans.

    Clinical Microbiology and Infection, Vol. 15, Núm. 10, pp. 954-957

2008

  1. Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 5, pp. 934-937

2007

  1. Abundance and phenotypic diversity of Escherichia coli isolates with diminished susceptibility to expanded-spectrum cephalosporins in faeces from healthy food animals after slaughter

    Veterinary Microbiology, Vol. 120, Núm. 3, pp. 363-369

2006

  1. Detection and characterization of Extended-Spectrum beta-lactamases (ESBLs) in Salmonella enterica strains of healthy food animals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 4, pp. 844-847

2005

  1. Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 3, pp. 1262-1264

2003

  1. Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 6, pp. 2056-2058

  2. ß-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain

    Microbial Drug Resistance, Vol. 9, Núm. 2, pp. 201-209

2001

  1. Erratum: Letter to the editor: Isolation of an SHV-12 β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections (Antimicrobial Agents and Chemotherapy (2000) 44:12 (3483-3484))

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 1, pp. 373

2000

  1. Isolation of an SHV-12 β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections [2]

    Antimicrobial Agents and Chemotherapy